Stephen M. Graham is co-chair of Fenwick & West’s Life Sciences Practice, is a partner in the corporate group and is a member of the firm’s executive committee. He is resident in the firm’s Seattle office, where he is the Managing Partner. Mr. Graham focuses his practice in the areas of private and public mergers and acquisitions, public offerings, private placements, and corporate governance matters, including advising boards of directors and audit, compensation and nominating/corporate governance committees, preparation and filing of periodic SEC reports, and other securities law compliance, including Sarbanes-Oxley Act matters and disclosure issues with respect to Rule 10b-5 and Regulation FD. His diverse practice is focused on the representation of emerging and established high growth companies. Mr. Graham has represented companies and investment banks in numerous initial public offerings, a wide variety of merger and acquisition transactions, and private offerings of debt and equity.
Mr. Graham has been recognized by Chambers USA as one of the top corporate and mergers and acquisitions lawyers in Washington. He is also a “Super Lawyer” award recipient, 2000 – 2011, is listed in Who’s Who in America by Marquis Biographical Reference, and is a member of Pi Sigma Alpha. Mr. Graham co-chairs the Securities and Exchange Commission’s Advisory Committee on Small and Emerging Companies. He is also active in community affairs, currently serving on the Board of Directors of the Fred Hutchinson Cancer Research Center, the Institute for Systems Biology and the Washington Biotechnology & Biomedical Association, where he is on the Executive Committee. He received his B.S. from Iowa State University and his J.D. from the Yale University School of Law.